NeoPharm, Inc.
NeoPharm Presents the Phase I Data for Patients with Metastatic Solid Tumors
Published in Cancer Weekly, December 1st, 2009
NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase I clinical trial of Liposome Encapsulated Docetaxel (LE-DT) an active component of Taxotere® at a joint International Conference of the American Association for Cancer Research (AACR), the National Cancer Institute (NCI) and the European Organization for Research and Treatment of Cancer (EORTC) being held in Boston, MA. This multicenter, open label dose escalation trial of LE-DT was performed at Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC and Scottsdale Clinical Research Institute/TGEN, Scottsdale, AZ.
Patients received 50, 65, 85, 110 and 132mg/m2 doses in a cohort...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-12-01)
More Articles from Cancer Weekly
- Georgetown University Medical Center
For many, mammography every other year has benefits of annual screening, but less harm - JAMA and Archives Journals
Treatment with folic acid, vitamin B12 associated with increased risk of cancer, death - Journal of the National Cancer Institute
Bladder cancer risks increase over time for smokers - Journal of the National Cancer Institute
News brief: Adverse symptom reporting by patients vs. clinicians - The Wistar Institute
Wistar researchers show targeting 'normal' cells in tumors slows growth - University of California - Davis - Health System
Text message reminders can encourage healthy action - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
